<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00334178</url>
  </required_header>
  <id_info>
    <org_study_id>LAXY-P001-R-2003</org_study_id>
    <nct_id>NCT00334178</nct_id>
  </id_info>
  <brief_title>Evaluation of the Efficacy and Safety of Laxymig速 as Prophylactic Treatment in Patients With Migraine</brief_title>
  <official_title>A Multi-Center, Randomized, Parallel, Double-Blind, Placebo-Controlled Study in Evaluation the Efficacy and Safety of Laxymig速 ER as Prophylactic Treatment in Patients With Migraine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lotus Pharmaceutical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lotus Pharmaceutical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy and safety of Laxymig速 ER compared with
      placebo in prophylactic monotherapy treatment of migraine headache.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate the efficacy and safety of Laxymig速 ER compared with
      placebo in prophylactic monotherapy treatment of migraine headache.

      Four weeks baseline, following with 12 weeks treatment phase. Subjects migraine are recorded
      by diary cards and re-evaluated by the investigator.

      Subject will have visit every 4-week (+/- 7 days).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2004</start_date>
  <completion_date type="Actual">September 2006</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change from baseline in the frequency of migraine attacks</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>change from baseline in 4-week in migraine periods of week 9 to 12;</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change from baseline in 4-week in migraine days of week 9 to 12;</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the proportion of subjects with a reduction of 50% or more in 4-week migraine frequencies;</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the proportion of subjects with a reduction of 50% or more in 4-week migraine periods;</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the proportion of subjects with a reduction of 50% or more in 4-week migraine days</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the average symptomatic medications usage</measure>
  </secondary_outcome>
  <enrollment type="Actual">74</enrollment>
  <condition>Migraine With Aura</condition>
  <condition>Migraine Without Aura</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Laxymig ER (drug)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of migraine with or without aura (typical aura with migraine
             headache)

          -  Subjects who had an average of two or more migraine frequencies per month during the 3
             months before screening

        Exclusion Criteria:

          -  Female subjects who are pregnant, lactating

          -  Chronic daily headache

          -  Previous treatment with three or more migraine prophylaxis medications failed

          -  Subjects with hepatic disease whose liver enzymes are over 2 times of upper limit of
             reference or significant dysfunction

          -  Coexisting medical, neurological, or psychiatric disorder that may hinder the study
             according to the investigator's judgment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shuu-Jiun Wang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Taipei Veterans General Hospital, Taiwan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Changhua Christian Hospital</name>
      <address>
        <city>Changhua</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chung-Ho Memorial Hospital, Kaohsiung Medical University</name>
      <address>
        <city>Kaohsiung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chang-Gung Memorial Hospital</name>
      <address>
        <city>LinKou</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chinese Medical University Hospital</name>
      <address>
        <city>Taichung</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SinLau Christian Hospital</name>
      <address>
        <city>Tainan</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Taipei Veterans General Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>112</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Taipei Medical University Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>September 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 5, 2006</study_first_submitted>
  <study_first_submitted_qc>June 5, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 6, 2006</study_first_posted>
  <last_update_submitted>September 6, 2007</last_update_submitted>
  <last_update_submitted_qc>September 6, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 10, 2007</last_update_posted>
  <keyword>Migraine</keyword>
  <keyword>Migraine prophylaxis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
    <mesh_term>Migraine with Aura</mesh_term>
    <mesh_term>Migraine without Aura</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

